 | 55S | Name: | 6-(cyclohexylmethoxy)-N-[4-(ethylsulfonyl)phenyl]-9H-purin-2-amine | Formula: | C20 H25 N5 O3 S | SMILES: | c4c(Nc3nc1ncnc1c(OCC2CCCCC2)n3)ccc(c4)S(=O)(CC)=O | InChi: | InChI=1S/C20H25N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h8-11,13-14H,2-7,12H2,1H3,(H2,21,22,23,24,25) | Definition date: | 2015-07-30 | Last modified: | 2024-09-27 | Release date: | 2015-09-16 | Identifier: | 6-(cyclohexylmethoxy)-N-[4-(ethylsulfonyl)phenyl]-9H-purin-2-amine |
|
 | 562 | Name: | N~5~-[N-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethyl)carbamimidoyl]-L-ornithine | Formula: | C12 H26 N7 O4 | SMILES: | NC(CCCNC(=N)NCCOCCOCCN=[N+]=N)C(=O)O | InChi: | InChI=1S/C12H25N7O4/c13-10(11(20)21)2-1-3-16-12(14)17-4-6-22-8-9-23-7-5-18-19-15/h10,15H,1-9,13H2,(H3-,14,16,17,20,21)/p+1/t10-/m0/s1 | Definition date: | 2015-07-31 | Last modified: | 2024-09-27 | Release date: | 2018-03-14 | Identifier: | N~5~-[N-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethyl)carbamimidoyl]-L-ornithine |
|
 | LTA | Name: | 4,8-DIAMINO-3-HYDROXY-OCTANOIC ACID ETHYL ESTER | Formula: | C10 H22 N2 O3 | SMILES: | O=C(OCC)CC(O)C(N)CCCCN | InChi: | InChI=1S/C10H22N2O3/c1-2-15-10(14)7-9(13)8(12)5-3-4-6-11/h8-9,13H,2-7,11-12H2,1H3/t8-,9-/m0/s1 | Synonyms: | STATINE ANALOGUE | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | ethyl (3S,4S)-4,8-diamino-3-hydroxyoctanoate |
|
 | 56A | Name: | 3-(8-phenyloctyl)-L-histidine | Formula: | C20 H29 N3 O2 | SMILES: | O=C(O)C(N)Cc1cncn1CCCCCCCCc2ccccc2 | InChi: | InChI=1S/C20H29N3O2/c21-19(20(24)25)14-18-15-22-16-23(18)13-9-4-2-1-3-6-10-17-11-7-5-8-12-17/h5,7-8,11-12,15-16,19H,1-4,6,9-10,13-14,21H2,(H,24,25)/t19-/m0/s1 | Definition date: | 2011-04-29 | Last modified: | 2024-09-27 | Identifier: | 3-(8-phenyloctyl)-L-histidine |
|
 | 56C | Name: | N~5~-{N-[2-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethoxy)ethyl]carbamimidoyl}-L-ornithine | Formula: | C14 H30 N7 O5 | SMILES: | NC(C(=O)O)CCCNC(=N)NCCOCCOCCOCC/N=[N+]=N | InChi: | InChI=1S/C14H29N7O5/c15-12(13(22)23)2-1-3-18-14(16)19-4-6-24-8-10-26-11-9-25-7-5-20-21-17/h12,17H,1-11,15H2,(H3-,16,18,19,22,23)/p+1/t12-/m0/s1 | Definition date: | 2015-08-03 | Last modified: | 2024-09-27 | Release date: | 2018-03-14 | Identifier: | N~5~-{N-[2-(2-{2-[2-(triaza-1,2-dien-2-ium-1-yl)ethoxy]ethoxy}ethoxy)ethyl]carbamimidoyl}-L-ornithine |
|
 | LTE | Name: | 1-[3-[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]propyl]-3-[(4~{S})-4-azanyl-5-oxidanylidene-pentyl]guanidine | Formula: | C18 H29 N9 O5 | SMILES: | N[CH](CCCNC(=N)NCCC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23)C(O)=O | InChi: | InChI=1S/C18H29N9O5/c19-9(17(30)31)3-1-5-22-18(21)23-6-2-4-10-12(28)13(29)16(32-10)27-8-26-11-14(20)24-7-25-15(11)27/h7-10,12-13,16,28-29H,1-6,19H2,(H,30,31)(H2,20,24,25)(H3,21,22,23)/t9-,10+,12+,13+,16+/m0/s1 | Definition date: | 2019-09-04 | Last modified: | 2024-09-27 | Release date: | 2020-09-30 | Identifier: | (2~{S})-5-[[~{N}-[3-[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]propyl]carbamimidoyl]amino]-2-azanyl-pentanoic acid |
|
 | 56G | Name: | N-[3-({4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}oxy)phenyl]prop-2-enamide | Formula: | C22 H26 N8 O2 | SMILES: | c1(nc(nc(c1)Nc2cc(nn2)C)Oc3cccc(c3)NC(=O)[C@H]=C)N4CCN(C)CC4 | InChi: | InChI=1S/C22H26N8O2/c1-4-21(31)23-16-6-5-7-17(13-16)32-22-25-18(24-19-12-15(2)27-28-19)14-20(26-22)30-10-8-29(3)9-11-30/h4-7,12-14H,1,8-11H2,2-3H3,(H,23,31)(H2,24,25,26,27,28) | Definition date: | 2015-08-04 | Last modified: | 2024-09-27 | Release date: | 2015-09-09 | Identifier: | N-[3-({4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}oxy)phenyl]prop-2-enamide |
|
 | 56I | Name: | [(1R,2R,3R,4R,5S)-2-(hydroxymethyl)-3,4,5-tris(oxidanyl)cyclohexyl]sulfamic acid | Formula: | C7 H15 N O7 S | SMILES: | OC[CH]1[CH](O)[CH](O)[CH](O)C[CH]1N[S](O)(=O)=O | InChi: | InChI=1S/C7H15NO7S/c9-2-3-4(8-16(13,14)15)1-5(10)7(12)6(3)11/h3-12H,1-2H2,(H,13,14,15)/t3-,4+,5-,6+,7+/m0/s1 | Definition date: | 2021-07-07 | Last modified: | 2024-09-27 | Release date: | 2022-07-13 | Identifier: | [(1~{R},2~{R},3~{R},4~{R},5~{S})-2-(hydroxymethyl)-3,4,5-tris(oxidanyl)cyclohexyl]sulfamic acid |
|
 | LTJ | Name: | 4-[(3S)-3-{[(2E)-but-2-enoyl]amino}piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide | Formula: | C20 H25 F N4 O2 | SMILES: | C3(CCCN(c1c2c(c(cc1F)C(=O)N)nc(C)c2C)C3)NC(C=[C@H]C)=O | InChi: | InChI=1S/C20H25FN4O2/c1-4-6-16(26)24-13-7-5-8-25(10-13)19-15(21)9-14(20(22)27)18-17(19)11(2)12(3)23-18/h4,6,9,13,23H,5,7-8,10H2,1-3H3,(H2,22,27)(H,24,26)/b6-4+/t13-/m0/s1 | Definition date: | 2019-03-13 | Last modified: | 2024-09-27 | Release date: | 2019-04-03 | Identifier: | 4-[(3S)-3-{[(2E)-but-2-enoyl]amino}piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide |
|
 | 56J | Name: | 3-(9H-fluoren-9-yl)propanal | Formula: | C16 H14 O2 | SMILES: | c1cc2c(cc1)c3c(C2CCC=O)cccc3 | InChi: | InChI=1S/C16H14O2/c17-16(18)10-9-15-13-7-3-1-5-11(13)12-6-2-4-8-14(12)15/h1-8,15H,9-10H2,(H,17,18) | Definition date: | 2015-08-04 | Last modified: | 2024-09-27 | Release date: | 2016-08-17 | Identifier: | 3-(9H-fluoren-9-yl)propanal |
|
 | LTN | Name: | L-TRYPTOPHANAMIDE | Formula: | C11 H13 N3 O | SMILES: | O=C(N)C(N)Cc2c1ccccc1nc2 | InChi: | InChI=1S/C11H13N3O/c12-9(11(13)15)5-7-6-14-10-4-2-1-3-8(7)10/h1-4,6,9,14H,5,12H2,(H2,13,15)/t9-/m0/s1 | Definition date: | 2002-08-08 | Last modified: | 2024-09-27 | Identifier: | L-tryptophanamide |
|
 | LTU | Name: | 2-Amino-3-hydroxy-3-[1-[2-(oxiran-2-yl)propan-2-yl]indol-3-yl]propanoic acid | Formula: | C16 H20 N2 O4 | SMILES: | CC(C)([CH]1CO1)n2cc([CH](O)[CH](N)C(O)=O)c3ccccc23 | InChi: | InChI=1S/C16H20N2O4/c1-16(2,12-8-22-12)18-7-10(14(19)13(17)15(20)21)9-5-3-4-6-11(9)18/h3-7,12-14,19H,8,17H2,1-2H3,(H,20,21)/t12-,13+,14-/m1/s1 | Synonyms: | (2~{S},3~{R})-2-azanyl-3-oxidanyl-3-[1-[2-[(2~{S})-oxiran-2-yl]propan-2-yl]indol-3-yl]propanoic acid | Definition date: | 2022-07-12 | Last modified: | 2024-09-27 | Release date: | 2023-03-29 | Identifier: | (2~{S},3~{R})-2-azanyl-3-oxidanyl-3-[1-[2-[(2~{S})-oxiran-2-yl]propan-2-yl]indol-3-yl]propanoic acid |
|
 | LV0 | Name: | ~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(1,3-thiazol-2-ylmethylamino)butan-2-yl]benzamide | Formula: | C21 H21 N3 O3 S | SMILES: | O[CH]([CH](Cc1ccccc1)NC(=O)c2ccccc2)C(=O)NCc3sccn3 | InChi: | InChI=1S/C21H21N3O3S/c25-19(21(27)23-14-18-22-11-12-28-18)17(13-15-7-3-1-4-8-15)24-20(26)16-9-5-2-6-10-16/h1-12,17,19,25H,13-14H2,(H,23,27)(H,24,26)/t17-,19+/m1/s1 | Definition date: | 2022-12-08 | Last modified: | 2024-09-27 | Release date: | 2023-03-29 | Identifier: | ~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(1,3-thiazol-2-ylmethylamino)butan-2-yl]benzamide |
|
 | 58A | Name: | 5'-O-[(R)-{[(S)-{(2R)-2,3-bis[(9E)-octadec-9-enoyloxy]propoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine | Formula: | C48 H85 N3 O15 P2 | SMILES: | O=C1N(C=CC(=N1)N)C2OC(C(C2O)O)COP(=O)(O)OP(O)(OCC(COC(CCCCCCCC=CCCCCCCCC)=O)OC(CCCCCCCC=[C@H]CCCCCCCC)=O)=O | InChi: | InChI=1S/C48H85N3O15P2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-43(52)61-37-40(64-44(53)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)38-62-67(57,58)66-68(59,60)63-39-41-45(54)46(55)47(65-41)51-36-35-42(49)50-48(51)56/h17-20,35-36,40-41,45-47,54-55H,3-16,21-34,37-39H2,1-2H3,(H,57,58)(H,59,60)(H2,49,50,56)/b19-17+,20-18+/t40-,41-,45-,46-,47-/m1/s1 | Synonyms: | cytidinediphosphate-dioleoylglycerol | Definition date: | 2015-08-19 | Last modified: | 2024-09-27 | Release date: | 2015-11-04 | Identifier: | 5'-O-[(R)-{[(S)-{(2R)-2,3-bis[(9E)-octadec-9-enoyloxy]propoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]cytidine |
|
 | 58E | Name: | (5aS,6S,9aS)-7-hydroxy-2,6,9a-trimethyl-3-(pyridin-3-yl)-4,5,5a,6,9,9a-hexahydro-2H-benzo[g]indazole-8-carbonitrile | Formula: | C20 H22 N4 O | SMILES: | OC=4C(C)C3CCc1c(nn(c1c2cccnc2)C)C3(C)CC=4C#N | InChi: | InChI=1S/C20H22N4O/c1-12-16-7-6-15-17(13-5-4-8-22-11-13)24(3)23-19(15)20(16,2)9-14(10-21)18(12)25/h4-5,8,11-12,16,25H,6-7,9H2,1-3H3/t12-,16-,20-/m0/s1 | Definition date: | 2015-08-20 | Last modified: | 2024-09-27 | Release date: | 2016-08-10 | Identifier: | (5aS,6S,9aS)-7-hydroxy-2,6,9a-trimethyl-3-(pyridin-3-yl)-4,5,5a,6,9,9a-hexahydro-2H-benzo[g]indazole-8-carbonitrile |
|
 | LVN | Name: | (3S)-4-oxo-L-valine | Formula: | C5 H9 N O3 | SMILES: | C[CH](C=O)[CH](N)C(O)=O | InChi: | InChI=1S/C5H9NO3/c1-3(2-7)4(6)5(8)9/h2-4H,6H2,1H3,(H,8,9)/t3-,4+/m1/s1 | Synonyms: | (2S,3S)-2-amino-3-methyl-4-oxo-butanoic acid | Definition date: | 2009-11-29 | Last modified: | 2024-09-27 | Identifier: | (2S,3S)-2-azanyl-3-methyl-4-oxo-butanoic acid |
|
 | LVS | Name: | 4-IODO-3-NITROPHENYL ACETYL-LEUCINYL-LEUCINYL-LEUCINYL-VINYLSULFONE | Formula: | C28 H43 I N4 O8 S | SMILES: | O=[N+]([O-])c1cc(cc(I)c1O)CC(=O)NC(C(=O)NC(C(=O)NC(C=C/S(=O)(=O)C)CC(C)C)CC(C)C)CC(C)C | InChi: | InChI=1S/C28H43IN4O8S/c1-16(2)10-20(8-9-42(7,40)41)30-27(36)23(12-18(5)6)32-28(37)22(11-17(3)4)31-25(34)15-19-13-21(29)26(35)24(14-19)33(38)39/h8-9,13-14,16-18,20,22-23,35H,10-12,15H2,1-7H3,(H,30,36)(H,31,34)(H,32,37)/t20-,22+,23+/m1/s1 | Definition date: | 2002-03-04 | Last modified: | 2024-09-27 | Identifier: | N-[(4-hydroxy-3-iodo-5-nitrophenyl)acetyl]-L-leucyl-N-{(1S)-3-methyl-1-[(Z)-2-(methylsulfonyl)ethenyl]butyl}-L-leucinamide |
|
 | LVX | Name: | (1~{R})-3,3-bis(fluoranyl)-~{N}-[(2~{R})-3-methoxy-1-oxidanylidene-1-[[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(1,3-thiazol-2-ylmethylamino)butan-2-yl]amino]propan-2-yl]cyclohexane-1-carboxamide | Formula: | C25 H32 F2 N4 O5 S | SMILES: | COC[CH](NC(=O)[CH]1CCCC(F)(F)C1)C(=O)N[CH](Cc2ccccc2)[CH](O)C(=O)NCc3sccn3 | InChi: | InChI=1S/C25H32F2N4O5S/c1-36-15-19(31-22(33)17-8-5-9-25(26,27)13-17)23(34)30-18(12-16-6-3-2-4-7-16)21(32)24(35)29-14-20-28-10-11-37-20/h2-4,6-7,10-11,17-19,21,32H,5,8-9,12-15H2,1H3,(H,29,35)(H,30,34)(H,31,33)/t17-,18-,19-,21+/m1/s1 | Definition date: | 2022-12-08 | Last modified: | 2024-09-27 | Release date: | 2023-03-29 | Identifier: | (1~{R})-3,3-bis(fluoranyl)-~{N}-[(2~{R})-3-methoxy-1-oxidanylidene-1-[[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(1,3-thiazol-2-ylmethylamino)butan-2-yl]amino]propan-2-yl]cyclohexane-1-carboxamide |
|
 | LW1 | Name: | thiophene-2-carbaldehyde | Formula: | C5 H4 O S | SMILES: | C(c1cccs1)=O | InChi: | InChI=1S/C5H4OS/c6-4-5-2-1-3-7-5/h1-4H | Definition date: | 2018-04-20 | Last modified: | 2024-09-27 | Release date: | 2019-06-12 | Identifier: | thiophene-2-carbaldehyde |
|
 | LW6 | Name: | 1H-indole-4-carbaldehyde | Formula: | C9 H7 N O | SMILES: | O=Cc1cccc2[NH]ccc12 | InChi: | InChI=1S/C9H7NO/c11-6-7-2-1-3-9-8(7)4-5-10-9/h1-6,10H | Definition date: | 2023-08-15 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | 1H-indole-4-carbaldehyde |
|
 | LW8 | Name: | trimethyl-[(2S)-1-oxidanyl-1-oxidanylidene-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)propan-2-yl]azanium | Formula: | C9 H16 N3 O2 S | SMILES: | C[N+](C)(C)[CH](CC1=CNC(=S)N1)C(O)=O | InChi: | InChI=1S/C9H15N3O2S/c1-12(2,3)7(8(13)14)4-6-5-10-9(15)11-6/h5,7H,4H2,1-3H3,(H2-,10,11,13,14,15)/p+1/t7-/m0/s1 | Definition date: | 2019-08-30 | Last modified: | 2024-09-27 | Release date: | 2020-08-26 | Identifier: | trimethyl-[(2~{S})-1-oxidanyl-1-oxidanylidene-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)propan-2-yl]azanium |
|
 | 59A | Name: | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE | Formula: | C12 H19 N O6 | SMILES: | O=C(NC(C(=O)O)C(C)CC)C1OC1C(=O)OCC | InChi: | InChI=1S/C12H19NO6/c1-4-6(3)7(11(15)16)13-10(14)8-9(19-8)12(17)18-5-2/h6-9H,4-5H2,1-3H3,(H,13,14)(H,15,16)/t6-,7-,8-,9-/m0/s1 | Synonyms: | CA059 | Definition date: | 2006-01-04 | Last modified: | 2024-09-27 | Identifier: | N-{[(2S,3S)-3-(ethoxycarbonyl)oxiran-2-yl]carbonyl}-L-isoleucine |
|
 | 59F | Name: | (2R,4R,5R)-2-[(1R)-1-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5-methyl-1,3-thiazinane-4-carboxylic acid | Formula: | C23 H29 N5 O8 S | SMILES: | C(N1C(C(=O)N(CC1)CC)=O)(NC(C(=O)NC(C2SCC(C(N2)C(O)=O)C)C=O)c3ccc(O)cc3)=O | InChi: | InChI=1S/C23H29N5O8S/c1-3-27-8-9-28(21(33)20(27)32)23(36)26-17(13-4-6-14(30)7-5-13)18(31)24-15(10-29)19-25-16(22(34)35)12(2)11-37-19/h4-7,10,12,15-17,19,25,30H,3,8-9,11H2,1-2H3,(H,24,31)(H,26,36)(H,34,35)/t12-,15+,16+,17+,19+/m0/s1 | Definition date: | 2015-08-27 | Last modified: | 2024-09-27 | Release date: | 2016-01-13 | Identifier: | (2R,4R,5R)-2-[(1R)-1-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5-methyl-1,3-thiazinane-4-carboxylic acid |
|
 | LWI | Name: | 2-(aminomethyl)-L-phenylalanine | Formula: | C10 H14 N2 O2 | SMILES: | NC(Cc1ccccc1CN)C(O)=O | InChi: | InChI=1S/C10H14N2O2/c11-6-8-4-2-1-3-7(8)5-9(12)10(13)14/h1-4,9H,5-6,11-12H2,(H,13,14)/t9-/m0/s1 | Definition date: | 2020-06-09 | Last modified: | 2024-09-27 | Release date: | 2021-03-31 | Identifier: | 2-(aminomethyl)-L-phenylalanine |
|
 | 59I | Name: | (2R,3R)-3-methyl-4-(2-oxidanylidene-2-propan-2-yloxy-ethyl)sulfanyl-2-[(2R)-3-oxidanyl-1-oxidanylidene-butan-2-yl]-2,3-dihydro-1H-pyrrole-5-carboxylic acid | Formula: | C15 H23 N O6 S | SMILES: | CC(C)OC(=O)CSC1=C(N[CH]([CH]1C)[CH](C=O)C(C)O)C(O)=O | InChi: | InChI=1S/C15H23NO6S/c1-7(2)22-11(19)6-23-14-8(3)12(10(5-17)9(4)18)16-13(14)15(20)21/h5,7-10,12,16,18H,6H2,1-4H3,(H,20,21)/t8-,9?,10?,12+/m1/s1 | Definition date: | 2021-08-12 | Last modified: | 2024-09-27 | Release date: | 2022-05-11 | Identifier: | (2~{R},3~{R})-3-methyl-4-(2-oxidanylidene-2-propan-2-yloxy-ethyl)sulfanyl-2-[(2~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-2,3-dihydro-1~{H}-pyrrole-5-carboxylic acid |
|